Xenetic Biosciences, Inc.
XBIO
$2.30
-$0.08-3.36%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.17M | 6.84M | 7.30M | 7.82M | 8.98M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 394.00K | 140.10K | 588.40K | 323.00K | 103.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 28.00K | 48.00K | 128.00K | 229.00K | 500.00K |
| Total Current Assets | 6.59M | 7.03M | 8.02M | 8.38M | 9.59M |
|
|
|||||
| Total Current Assets | 6.59M | 7.03M | 8.02M | 8.38M | 9.59M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 313.90K | 1.02M | 1.02M | 1.02M | 1.02M |
| Total Assets | 6.90M | 8.05M | 9.03M | 9.39M | 10.61M |
|
|
|||||
| Total Accounts Payable | 283.60K | 243.30K | 283.60K | 210.50K | 240.80K |
| Total Accrued Expenses | 610.60K | 766.10K | 1.30M | 506.00K | 568.80K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 894.30K | 1.01M | 1.59M | 716.50K | 809.60K |
|
|
|||||
| Total Current Liabilities | 894.30K | 1.01M | 1.59M | 716.50K | 809.60K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 894.30K | 1.01M | 1.59M | 716.50K | 809.60K |
|
|
|||||
| Common Stock & APIC | 208.23M | 208.20M | 208.17M | 208.13M | 208.06M |
| Retained Earnings | -197.19M | -196.14M | -195.70M | -194.43M | -193.23M |
| Treasury Stock & Other | -5.03M | -5.03M | -5.03M | -5.03M | -5.03M |
| Total Common Equity | 6.01M | 7.03M | 7.44M | 8.68M | 9.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.80K | 1.80K | 1.80K | 1.80K | 1.80K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.80K | 1.80K | 1.80K | 1.80K | 1.80K |
|
|
|||||
| Total Common Equity | 6.01M | 7.03M | 7.44M | 8.68M | 9.79M |
| Total Preferred Equity | 1.80K | 1.80K | 1.80K | 1.80K | 1.80K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.01M | 7.04M | 7.45M | 8.68M | 9.80M |
|
|
|||||
